Generated by GPT-5-mini| Angel Raich | |
|---|---|
| Name | Angel Raich |
| Birth date | c. 1970s |
| Birth place | California, United States |
| Known for | Litigation concerning medical marijuana and federal power |
Angel Raich is a California woman who became a central figure in a landmark legal dispute over medical marijuana, federal drug enforcement, and the constitutional scope of Congressional power. Her case reached the Supreme Court as Gonzales v. Raich, prompting national debate involving federal agencies, state legislatures, advocacy groups, and academic commentators. The litigation influenced litigation strategies by civil liberties organizations and shaped interactions among federal, state, and local authorities.
Angel Raich grew up in California, where she became involved with communities affected by chronic illness and alternative therapies. Her situation intersected with movements including California Proposition 215, advocacy by organizations such as the Drug Policy Alliance and the National Organization for the Reform of Marijuana Laws, and public health discussions involving practitioners affiliated with University of California, San Francisco and community clinics. Raich's circumstances attracted attention from activists who had been influenced by figures like Dennis Peron, Brownie Mary, and policy debates linked to the administrations of Presidents Bill Clinton and George W. Bush.
Raich's dispute originated when federal law enforcement actions intersected with California's implementation of Compassionate Use Act of 1996 (Proposition 215) and subsequent state statutes and regulations administered by authorities in California State Legislature and county health agencies. Plaintiffs included private citizens and medical providers represented by attorneys from organizations such as the American Civil Liberties Union and the Institute for Justice, with amici from groups like the AIDS Coalition to Unleash Power and the California Medical Association. The case was heard in the United States District Court for the Northern District of California, where judges considered precedents including Wickard v. Filburn, Lochner v. New York, and United States v. Lopez. District proceedings involved motions invoking the Controlled Substances Act and enforcement actions by the Drug Enforcement Administration and the Department of Justice under Attorneys General from the United States Department of Justice.
The Supreme Court granted certiorari, and the case was argued during the Roberts Court era with parties including the Solicitor General of the United States and counsel referencing precedents such as Gonzales v. Oregon, Raich v. Gonzales filings, and doctrines articulated in Heart of Atlanta Motel, Inc. v. United States and Katzenbach v. McClung. The Court's majority opinion, authored by Justice John Paul Stevens or Justice Antonin Scalia depending on interpretive accounts, applied the Commerce Clause jurisprudence rooted in Wickard v. Filburn and addressed the scope of Congressional authority under the Commerce Clause and the Necessary and Proper Clause relative to the Controlled Substances Act. The decision held that Congress could regulate locally grown marijuana intended for personal medical use when such regulation was part of a broader regulatory scheme, with separate opinions and dissents by Justices including Sandra Day O'Connor, Antonin Scalia, Stephen Breyer, Ruth Bader Ginsburg, Anthony Kennedy, and Clarence Thomas weighing federalism concerns and precedent from United States v. Morrison and Gonzales v. Raich (2005) commentary.
Scholars and litigants debated whether the ruling expanded federal preemption over state statutes such as the Compassionate Use Act of 1996 and whether it altered principles established in cases like United States v. Darby and Hodel v. Virginia Surface Mining & Reclamation Association, Inc.. The decision engaged constitutional topics including the Commerce Clause, Tenth Amendment federalism limits, and the Supremacy Clause. Law review articles in publications associated with Harvard Law School, Yale Law School, Columbia Law School, Stanford Law School, and the University of Chicago Law School analyzed the decision's implications for criminal procedure, administrative enforcement by the Drug Enforcement Administration, and prosecutorial discretion as exercised by the United States Attorney General. The case influenced litigation strategies in subsequent matters before circuits such as the Ninth Circuit and triggered commentary in outlets connected with The New York Times, The Washington Post, and academic presses including Oxford University Press.
Gonzales v. Raich affected enforcement by federal agencies including the Drug Enforcement Administration, Federal Bureau of Investigation, and the Department of Justice, and shaped interactions with state programs in jurisdictions such as California, Colorado, Washington (state), Oregon, and later states that enacted statutes modeled on initiatives like Proposition 215 and measures in state legislatures. Advocacy groups including the Marijuana Policy Project, NORML, Drug Policy Alliance, and public health organizations such as the American Public Health Association adjusted strategies for state ballot measures and litigation. The decision informed federal funding conditions applied by agencies like the Centers for Disease Control and Prevention and influenced legislation debated in the United States Congress, including bills considered by committees such as the House Committee on Energy and Commerce and the Senate Judiciary Committee.
After the Supreme Court decision, Raich remained a reference point in policy debates, scholarly work at institutions like Georgetown University Law Center and New York University School of Law, and litigation over state-federal conflicts including cases before the Ninth Circuit Court of Appeals and petitions to the Supreme Court. Policymakers from administrations of Barack Obama and Donald Trump addressed enforcement priorities shaped by the precedent, and state-level reforms progressed in legislatures and ballot initiatives involving policymakers from California State Assembly and executive offices. Raich's case is cited in contemporary discussions of federalism, criminal justice reform, and public health regulation in forums including the Brookings Institution and the Cato Institute.